Production (Stage)
IRadimed Corporation
IRMD
$57.88
-$0.26-0.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.39% | 11.87% | 14.09% | 26.95% | 30.37% |
| Total Depreciation and Amortization | -2.86% | 6.85% | 722.71% | 628.69% | 92.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.41% | 28.69% | 12.92% | 10.84% | 0.86% |
| Change in Net Operating Assets | 145.59% | 163.43% | 141.39% | -350.04% | -173.08% |
| Cash from Operations | 104.95% | 90.30% | 87.03% | 4.56% | -4.23% |
| Capital Expenditure | -769.22% | -7.59% | 19.81% | 68.16% | 81.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.17% | -43.28% | 4.87% | 36.86% | -30.10% |
| Cash from Investing | -535.35% | -10.11% | 18.52% | 64.58% | 74.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -83.25% | -83.25% | 2,265.75% | 110.35% | 136.23% |
| Repurchase of Common Stock | -18.59% | -12.73% | -53.25% | -60.70% | -125.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.42% | -3.44% | 10.94% | 25.31% | 39.68% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.78% | -4.97% | 10.38% | 23.80% | 37.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.50% | 130.15% | 156.25% | 142.82% | 130.64% |